THYROCARE TECHNOLOGIES
|
THYROCARE TECHNOLOGIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 10.27 | 17.12 | 13.42 | 12.47 | 33.28 |
| CEPS(Rs) | 13.91 | 9.18 | 7.33 | 6.49 | 13.23 |
| DPS(Rs) | 14.00 | 21.00 | 18.00 | 18.00 | 15.00 |
| Book NAV/Share(Rs) | 36.36 | 102.36 | 98.67 | 100.09 | 98.89 |
| Tax Rate(%) | 23.50 | 37.60 | 27.60 | 27.35 | 22.65 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 29.66 | 27.72 | 24.26 | 23.27 | 40.03 |
| EBIT Margin(%) | 26.16 | 21.70 | 17.75 | 17.74 | 39.22 |
| Pre Tax Margin(%) | 25.68 | 21.16 | 16.78 | 16.82 | 38.67 |
| PAT Margin (%) | 19.64 | 13.20 | 12.15 | 12.22 | 29.91 |
| Cash Profit Margin (%) | 26.71 | 21.24 | 20.37 | 19.57 | 35.66 |
| Performance Ratios | |||||
| ROA(%) | 21.42 | 13.33 | 10.00 | 8.00 | 25.38 |
| ROE(%) | 29.05 | 17.04 | 13.21 | 12.23 | 37.18 |
| ROCE(%) | 38.30 | 27.24 | 18.75 | 17.61 | 48.42 |
| Asset Turnover(x) | 1.09 | 1.01 | 0.82 | 0.65 | 0.85 |
| Sales/Fixed Asset(x) | 1.45 | 1.32 | 1.19 | 1.19 | 1.49 |
| Working Capital/Sales(x) | 3.16 | 3.18 | 3.04 | 2.69 | 2.87 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.69 | 0.76 | 0.84 | 0.84 | 0.67 |
| Receivable days | 32.33 | 30.92 | 41.03 | 61.79 | 42.73 |
| Inventory Days | 20.91 | 24.97 | 23.99 | 18.09 | 14.84 |
| Payable days | 117.68 | 111.10 | 70.18 | 45.30 | 44.68 |
| Valuation Parameters | |||||
| PER(x) | 34.07 | 13.24 | 44.13 | 11.48 | 7.75 |
| PCE(x) | 25.14 | 24.69 | 26.92 | 22.07 | 19.49 |
| Price/Book(x) | 9.62 | 6.64 | 6.00 | 4.29 | 7.82 |
| Yield(%) | 4.00 | 3.09 | 3.04 | 4.19 | 1.94 |
| EV/Net Sales(x) | 6.63 | 5.16 | 5.45 | 4.26 | 6.93 |
| EV/Core EBITDA(x) | 19.62 | 17.24 | 21.05 | 17.15 | 15.39 |
| EV/EBIT(x) | 25.36 | 23.80 | 30.71 | 24.04 | 17.66 |
| EV/CE(x) | 9.39 | 6.49 | 5.68 | 4.20 | 7.75 |
| M Cap / Sales | 6.71 | 5.24 | 5.48 | 4.32 | 6.95 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 20.61 | 20.19 | 8.58 | -10.56 | 19.05 |
| Core EBITDA Growth(%) | 36.10 | 38.99 | 13.12 | -50.58 | 44.25 |
| EBIT Growth(%) | 45.35 | 46.96 | 8.66 | -59.55 | 50.60 |
| PAT Growth(%) | 79.45 | 30.59 | 7.97 | -63.46 | 55.67 |
| EPS Growth(%) | -40.04 | 27.62 | 7.58 | -62.52 | 57.45 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | 0.04 | - | - |
| Current Ratio(x) | 3.39 | 2.77 | 3.08 | 3.54 | 1.95 |
| Quick Ratio(x) | 2.95 | 2.39 | 2.55 | 3.18 | 1.84 |
| Interest Cover(x) | 54.76 | 39.89 | 18.36 | 19.34 | 71.94 |
| Total Debt/Mcap(x) | - | - | 0.01 | - | - |
Compare Financial Ratios of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹8,236.2 Cr | -4.2% | 3.1% | 66.1% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹123,558.0 Cr | 1.1% | 4% | 22.3% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹109,281.0 Cr | 2.5% | 13% | -7% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹72,038.1 Cr | -0.9% | -1.3% | 30.3% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹40,025.1 Cr | 4.3% | 3.6% | 4.8% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹39,809.8 Cr | -5% | 1.4% | 34.6% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | -4.2% |
3.1% |
66.1% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses
